Cisplatin in combination with 5-fluorouracil and epirubicin in advanced non-small cell lung carcinoma (NSCLC)

被引：0
|
作者：
Khodadad, K [1 ]
Shamshirsaz, AA [1 ]
Azadi, A [1 ]
Aghili, N [1 ]
Karimi, S [1 ]
Tahbaz, M [1 ]
机构：
[1] Natl Res Inst TB & Lung Dis, Tehran, Iran
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81003-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S251 / S252
页数：2
相关论文
共 50 条
  • [41] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [42] Carboplatin, in combination with epirubicin and 5-fluorouracil or capecitabine for advanced oesphagogastric cancer patients not suitable for standard cisplatin based combination treatment
    Abdul, Razak A.
    Lyon, S.
    Yates, C.
    Todd, R.
    Atherton, P.
    Mulvenna, P.
    Sumpter, K.
    Coxon, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 52 - 52
  • [43] Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study
    van den Heuvel, M. M.
    Belderbos, J.
    Dalesio, O.
    van der Pol, M.
    Uitterhoeve, L.
    van de Vaart, P.
    Verheij, M.
    van Zandwijk, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN THE MANAGEMENT OF METASTATIC NON-SMALL-CELL LUNG-CANCER
    FLAHERTY, L
    WOZNIAK, A
    REDMAN, B
    KRAUT, M
    MARTINO, S
    HEILBRUN, L
    VALDIVIESO, M
    CANCER, 1991, 68 (05) : 944 - 947
  • [45] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [46] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [47] CISPLATIN AND CONTINUOUS-INFUSION VINDESINE AND 5-FLUOROURACIL IN NON-SMALL-CELL LUNG-CANCER (NSCLC) (ATTIT-002)
    RIGGI, M
    CVITKOVIC, E
    DECREMOUX, H
    RUFFIE, P
    MONNET, I
    VOISIN, S
    VILLALOBOS, W
    AZLI, N
    SALTIEL, JC
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (13) : 1914 - 1915
  • [48] 5-FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE (FEC COMBINATION) IN ADVANCED BREAST-CANCER
    ZAMAGNI, C
    MARTONI, A
    ERCOLINO, L
    BARONI, M
    TANNEBERGER, S
    PANNUTI, F
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (02) : 126 - 129
  • [49] Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15
    Cortesi, E
    Ramponi, S
    Corona, M
    Moscetti, L
    Grifalchi, F
    Oliva, A
    Lembo, A
    Gasperoni, S
    Padovani, A
    LUNG CANCER, 2001, 31 (2-3) : 271 - 276
  • [50] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
12345